LEXICON PHARMACEUTICALS, INC. filed a Form D with the Securities and Exchange Commission on 2026-02-17.
LEXICON PHARMACEUTICALS, INC. filed a Form D notice of an exempt securities offering with the SEC on February 17, 2026. The filing reports $55.67M sold. Its industry group is Pharmaceuticals. It names Raymond Debbane (Director), Phillipe Amouyal (Director), Samuel Barker (Director) (SEC Form D, February 17, 2026).
Sell to companies like LEXICON PHARMACEUTICALS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-02-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns LEXICON PHARMACEUTICALS, INC.
Free to see. No signup.
More on the people and the money behind LEXICON PHARMACEUTICALS, INC., from the filings we hold.
Pharmaceuticals raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when LEXICON PHARMACEUTICALS, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when LEXICON PHARMACEUTICALS, INC. raises, hires or launches. No email unless you switch it on.
Watch LEXICON PHARMACEUTICALS, INC. →Get the full cited report on LEXICON PHARMACEUTICALS, INC.
What the filing shows about LEXICON PHARMACEUTICALS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on LEXICON PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for LEXICON PHARMACEUTICALS, INC. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on LEXICON PHARMACEUTICALS, INC. See pricing
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $55.67M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Raymond Debbane is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Phillipe Amouyal is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Samuel Barker is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Ivan Cheung is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Scott Coiante is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Brian Crum is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Lisa DeFrancesco is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Mike Exton is named as Executive Officer and Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Rachel Martens is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Suma Gopinathan is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Craig Granowitz is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Rachel Martens is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Wendy McDermott is named as Executive Officer on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Christopher Sobecki is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Diane Sullivan is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
Judith Swain is named as Director on the Form D that LEXICON PHARMACEUTICALS, INC. filed with the SEC on 17 February 2026, one of 16 people that filing names.
16 people named on the filing — 9 holding an executive role and 7 as directors only.
Named as of the 2026-02-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Of the 15 names on this filing, 12 are drawn here to keep the picture readable. The People tab lists them all.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about LEXICON PHARMACEUTICALS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on LEXICON PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LEXICON PHARMACEUTICALS, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist LEXICON PHARMACEUTICALS, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind LEXICON PHARMACEUTICALS, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for LEXICON PHARMACEUTICALS, INC.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Houston
https://mentionfox.com/funding/lexicon-pharmaceuticals-inc-form-d-26000001